Reuters US Business

Apple Watches violate AliveCor patents but import ban on hold -U.S. ITC

By Blake Brittain (Reuters) -Apple Inc’s Apple Watches with an electrocardiogram (ECG) function infringe patents belonging to medical device maker AliveCor Inc, the U.S. International Trade Commission affirmed on Thursday. The ITC said imports of the infringing watches should be banned, but that it would not enforce a ban until appeals were finished in a …

Apple Watches violate AliveCor patents but import ban on hold -U.S. ITC Read More »

Marketmind: Grinch (re)appears

A look at the day ahead in European and global markets from Ankur Banerjee Ignoring a hawkish Fed, investors attempted the briefest of Santa rallies this week but revised U.S. GDP data and relatively low claims for unemployment benefits have brought back worries of higher-for-longer interest rates. And so the safe-haven U.S. dollar is back …

Marketmind: Grinch (re)appears Read More »

Zimbabwe’s night markets cushion crisis-weary citizens from inflation

By Nyasha Chingono HARARE (Reuters) – As dusk descends on the dimly lit central business district of Zimbabwe’s capital Harare, a steady stream of home-bound workers flows into a sea of informal traders hawking a mixture of basic foods, clothes and electronic devices. The crowds of night-time street traders have expanded as the southern African …

Zimbabwe’s night markets cushion crisis-weary citizens from inflation Read More »

Airlines scrap 4,400 U.S. flights as winter storm disrupts holiday travel

By David Shepardson and Aishwarya Nair WASHINGTON (Reuters) -Over 4,400 flights have been canceled over a two-day period as a powerful winter storm hits the United States, coinciding with the start of a holiday season that some predict could be the busiest ever. More than 2,350 U.S. flights had been canceled Thursday and another 2,120 …

Airlines scrap 4,400 U.S. flights as winter storm disrupts holiday travel Read More »

Crypto firm Bullish, Far Peak SPAC call off $9 billion deal

(Reuters) – Cryptocurrency firm Bullish and special purpose acquisition company Far Peak Acquisition Corp said on Thursday they had called off their $9 billion merger deal. (Reporting by Anirban Chakroborti in Bengaluru; Editing by Anil D’Silva)

Mersana signs deal with Merck KGaA for cancer therapy development

(Reuters) – Mersana Therapeutics Inc said on Thursday it had signed a deal for developing cancer drugs with Germany’s Merck KGaA that has the potential to generate up to $800 million in milestone payments. Mersana would receive $30 million in an upfront payment, which would be used to develop drugs known as antibody-drug conjugates (ADCs), …

Mersana signs deal with Merck KGaA for cancer therapy development Read More »

Close Bitnami banner
Bitnami